Avapritinib Decreased Symptom Burden in Patients With Indolent Systemic Mastocytosis in the Registrational Double-Blind, Placebo-Controlled PIONEER Study

Bibliographic Details
Title: Avapritinib Decreased Symptom Burden in Patients With Indolent Systemic Mastocytosis in the Registrational Double-Blind, Placebo-Controlled PIONEER Study
Authors: Giannetti, Matthew, Akin, Cem, Livideanu, Cristina Bulai, Sabato, Vito, Van Daele, Paul, Pongdee, Thanai, Barete, Stéphane, Vadas, Peter, Maurer, Marcus, Siebenhaar, Frank, Triggiani, Massimo, Bonadonna, Patrizia, Hartmann, Karin, Guilarte, Mar, Ogbogu, Princess, Gaudy, Caroline, Bidollari, Ilda, Green, Teresa, Lin, Hui-Min, Roche, Maria, Sullivan, Erin, Castells, Mariana, Elberink, Hanneke Oude
Source: In The Journal of Allergy and Clinical Immunology February 2024 153(2) Supplement:AB254-AB254
Database: ScienceDirect
More Details
ISSN:00916749
DOI:10.1016/j.jaci.2023.11.811
Published in:The Journal of Allergy and Clinical Immunology
Language:English